Lunsumio

Medicinal product

(Invented) name

Lunsumio

Active substance (s)

Mosunetuzumabas

Strength

30 mg

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FX25, mosunetuzumab

Marketing authorisation holder

Roche Registration GmbH, Vokietija

Date of authorisation

2022-06-03

Date of renewal

Documents

Lunsumio paciento kortele.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	30 ml
Mosunetuzumabas	30 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108841	94947	1094947	flakonas	30 ml N1		Receptinis	EU/1/22/1649/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-06-03	Registruotas